Combining Cellular Bioenergetics with Metabolomics

Agilent at Metabolomics 2025

Agilent at Metabolomics 2025

We are looking forward to welcoming you to the Metabolomics Society Conference in Prague!

Join us at Booth #P2 to hear about the latest innovative solutions to address the challenges of metabolic research. Our experts will be available to discuss:

  • End-to-end metabolomics solutions
  • High-resolution MS for metabolomics analysis
  • Cell analysis solutions to study metabolism
  • Software solutions for metabolomics studies

Combining Cellular Bioenergetics with Metabolomics. Take your metabolomics workflow to the next level

Agilent Lunch Seminar

Agilent Lunch Seminar

Join us on Thursday 26 June at 12:25 to 1:25 pm, South Hall 2, to learn how to take your metabolomics workflow to the next level.

A Comprehensive Suite of Next Generation Metabolomics Tools, enabling insights in 3D.
Dan Cuthbertson, Director, Global Life Science Research Market at Agilent

Combining cellular analysis with mass spectrometry tools yield provide deeper mechanistic insights into drug discovery and metabolomics studies by unlocking data that mass spectrometry cannot provide alone. New developments from Agilent enable these synergies in 3D model systems providing even more powerful insights.

Investigating the Influence of PFAS on Cellular Metabolism in HeLa and HepG2 Cell Lines Using Seahorse Real-Time Cell Metabolic Analysis and Mass Spectrometry Techniques
David Beale, Senior Research Scientist , Adjunct Professor of RMIT University

This study investigates the metabolic and lipidomic disruptions in HeLa and HepG2 cell lines exposed to PFAS and regulatory concentrations used in drinking water and at higher concentrations typically used in toxicology studies. Using the Agilent Seahorse Real-Time Cell Metabolic Analyser coupled with Mass Spectrometry techniques, we observed significant alterations in cellular energy metabolism and biochemical pathways and differential response based on cell lines.

The New Agilent Seahorse XF Flex Analyzer Takes Real Time Metabolic Analysis to the Third Dimension

Agilent Oral Presentation

Agilent Vendor Session

Join us on on Tuesday, June 24
from 3:30, at the Congress Hall.

Sofia Vikstrom. Field Application Scientist Manager

The new Agilent Seahorse XF Flex 24-well platform is redefining what’s possible in functional metabolic analysis, empowering researchers to explore metabolism across a broader range of model systems than ever before. From traditional 2D cell cultures to cutting-edge 3D organoids, spheroids, and tissue models, this advanced platform delivers a more physiologically relevant view of metabolism in disease. By bridging the gap between in vitro research and real-world biology, the Seahorse XF Flex enhances research translatability, unlocking deeper insights into cellular function and disease mechanisms.

Agilent Posters

  • Agilent’s end-to-end solutions help you take your metabolomics workflows to the next level
    Daniel Cuthbertson. Agilent Technologies, Santa Clara, US
  • A workflow for simultaneous quantitation and discovery analysis using Revident LC-QTOF to follow CRISPRi knockdowns in E. coli metabolism
    Anna Walke(1),*, Stefan Schäbler (1), Karen E. Yannell (2), Daniel Cuthbertson (2)
    (1) Agilent Technologies, Waldbronn, Germany; (2) Agilent Technologies, Santa Clara, US
  • Improved drug metabolite identification with a streamlined software workflow
    Mark Sartain(1), Martin Andre Hoffmann(2), Lee Bertram(1), Andrew McEachran(1), James S. Pyke(1)
    (1)Agilent Technologies, Inc., Santa Clara, CA, USA; (2)Bright Giant GmbH, Jena, Germany
  • Quantification of underivatized acylcarnitines and carnitine intermediates using RP chromatography and ion funnel triple quadrupole in fecal samples
    Bianca Silva(1), Ruben J. F. Ramos(2), Justin Cross, Karen Yannell(1), Daniel Cuthbertson(1)
    (1) Agilent Technologies (2)Cell Metabolism Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY
  • Discovery workflows: is hi-res always necessary?
    Hannah Florance, Karen Yannell, Cate Zimmermaker, Genevieve C. Van de Bittner , Mark Sartain, Daniel Cuthbertson, Agilent Technologies

For research use only. Not for use in diagnostic procedures.

DE-007371

Contact Us

If you require a quote or more information on our solutions please complete the form below.

Your Personal Data

* This field is required

Please select your application interest(s) from choices below.

Please select your technique(s) from choices below.

Your Purchase Plan











For full details of how we will treat your information please view our privacy policy: www.agilent.com/home/privacy-policy